查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1702218

2025 年至 2033 年体外诊断市场规模、份额、趋势及预测（按测试类型、产品、可用性、应用、最终用户和地区）

In Vitro Diagnostics Market Size, Share, Trends and Forecast by Test Type, Product, Usability, Application, End User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球体外诊断市场规模价值 1,167 亿美元。展望未来， IMARC Group估计到 2033 年市场规模将达到 1,815 亿美元，2025 年至 2033 年的复合年增长率为 5.0%。北美目前占据市场主导地位，到 2024 年其市占率将超过 42.7%。传染病患病率的上升、技术的不断进步、消费者偏好向个人化医疗的转变以及老年人口的增加是推动体外诊断市场份额的主要因素。

体外诊断 (IVD) 是指在生物体外进行的医学测试和程序，通常在实验室环境中，使用血液、尿液、组织或其他体液等样本。这些测试旨在检测、诊断和监测各种医疗状况和疾病。与在生物体内进行的体内诊断不同，体外诊断涉及在受控实验室条件下检查生物样本。 IVD 测试是现代医疗保健不可或缺的一部分，为医疗保健专业人员提供关键讯息，以便他们就患者护理做出明智的决策。这些测试在疾病筛检、早期诊断、治疗选择和监测治疗进展中发挥着至关重要的作用。它们应用于各医学专业，包括临床化学、微生物学、血液学、免疫学、分子诊断学等。

由于慢性病和传染病的发病率不断上升，市场正在经历显着增长。随着人口老化和生活方式的改变，糖尿病、心血管疾病和癌症等慢性疾病变得更加普遍。体外诊断为医疗保健专业人员提供了这些疾病的早期发现和有效管理的重要见解，从而改善了患者的治疗效果并降低了医疗保健成本。此外，技术进步和自动化整合彻底改变了 IVD 市场。自动化系统（例如即时诊断设备和分子诊断）简化了诊断过程，从而能够更快、更准确地获得结果。此外，人们对个人化医疗和精准诊断的日益关注也推动了对专门体外诊断测试的需求。这些测试有助于根据个别患者的特定基因和分子特征制定治疗计划，优化治疗结果并最大限度地减少不良反应。

体外诊断市场趋势/驱动因素：

各种技术进步与自动化

技术创新的快速步伐彻底改变了体外诊断（IVD）市场。分子诊断、次世代定序和微流体等先进技术使得检测方法更加准确和灵敏。自动化简化了诊断流程，减少了人为错误并提高了效率。诸如即时诊断测试设备之类的自动化系统可以更快地获得结果，从而能够及时做出患者护理决策。这些进步不仅提高了诊断的准确性，而且还有助于节省成本和改善患者的治疗效果。此外，自动化将诊断测试的范围扩展到偏远或资源有限的地区，解决了医疗保健差距并改善了患者获得基本诊断服务的机会。人工智慧和机器学习演算法的融合进一步增强了诊断系统的分析能力，使得测试解释更加精确和个人化。随着技术的不断进步，体外诊断市场预计将持续成长，诊断测试和应用的范围也将持续扩大。

慢性病盛行率不断上升

糖尿病、心血管疾病和癌症等慢性疾病的盛行率不断上升，成为 IVD 市场成长的主要驱动力。随着人口老化和生活方式的改变，慢性病在全球范围内变得更加普遍。体外诊断在这些疾病的早期发现、监测和管理中发挥着至关重要的作用。诊断测试可帮助医疗保健专业人员做出明智的治疗决策，从而更好地管理疾病并改善患者的生活品质。此外，慢性病的流行促使人们转向预防性医疗保健。早期发现和介入对于预防慢性病进展和减轻医疗系统负担至关重要。体外诊断有助于早期筛检和识别风险因素，从而及时采取预防措施。对预防性医疗保健的重视促使人们在常规健康检查和健康计划中采用 IVD 测试。

个人化医疗日益受到重视

人们对个人化医疗的日益关注对 IVD 市场产生了重大影响。个人化医疗旨在根据患者的基因组成、生活方式和其他因素为其量身定制医疗方案。体外诊断，例如基因检测和伴随诊断，可以提供有关患者独特特征的关键见解，从而实现有针对性的治疗并避免不必要的治疗或不良反应。精准诊断借助下一代定序 (NGS) 和伴随诊断等先进技术，有助于识别特定的疾病亚型和分子标靶。随着精准医疗日益受到重视，对专门诊断测试的需求持续上升。医疗保健提供者和製药公司正在增加对研发的投资，以识别新的生物标记并创造创新的诊断解决方案来支持精准医疗计划。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球体外诊断市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依测试类型

  • 临床化学
  • 分子诊断
  • 免疫诊断
  • 血液学
  • 其他的

第七章：市场区隔：依产品

  • 试剂和试剂盒
  • 仪器

第八章：市场区隔：依可用性

  • 免洗体外诊断设备
  • 可重复使用的体外诊断设备

第九章：市场区隔：依应用

  • 传染病
  • 糖尿病
  • 癌症/肿瘤学
  • 心臟病学
  • 自体免疫疾病
  • 肾臟病学
  • 其他的

第十章：市场区隔：依最终用户

  • 医院实验室
  • 临床实验室
  • 即时检验中心
  • 学术机构
  • 患者
  • 其他的

第 11 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第 12 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 13 章：价值链分析

第 14 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 15 章：价格分析

第 16 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Agilent Technologies Inc.
    • Biomerieux SA
    • Bio-Rad Laboratories Inc.
    • F. Hoffmann-La Roche Ltd
    • Fujifilm Holdings Corporation
    • Illumina Inc.
    • Qiagen NV
    • Quest Diagnostics
    • Shimadzu Corporation
    • Siemens Healthcare GmbH
    • Sysmex Corporation
Product Code: SR112025A6467

The global in vitro diagnostics market size was valued at USD 116.7 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 181.5 Billion by 2033, exhibiting a CAGR of 5.0% from 2025-2033. North America currently dominates the market, holding a market share of over 42.7% in 2024. The rising prevalence of infectious diseases, the continuous technological advancements, shifting consumer preferences towards personalized medicine, and increasing geriatric population are among the primary factors driving the in vitro diagnostics market share.

In vitro diagnostics (IVD) refers to medical tests and procedures that are performed outside the living organism, typically in a laboratory setting, using samples such as blood, urine, tissue, or other body fluids. These tests are designed to detect, diagnose, and monitor various medical conditions and diseases. Unlike in vivo diagnostics, which are conducted within the living body, in vitro diagnostics involve the examination of biological specimens in controlled laboratory conditions. IVD tests are an integral part of modern healthcare, providing crucial information to healthcare professionals for making informed decisions about patient care. These tests play a vital role in disease screening, early diagnosis, treatment selection, and monitoring treatment progress. They are used across various medical specialties, including clinical chemistry, microbiology, hematology, immunology, molecular diagnostics, and more.

The market is experiencing significant growth, driven by the increasing prevalence of chronic diseases and infectious conditions. With the rise in aging populations and lifestyle changes, chronic diseases such as diabetes, cardiovascular disorders, and cancer have become more prevalent. In vitro diagnostics provide healthcare professionals with essential insights into the early detection and effective management of these conditions, leading to improved patient outcomes and reduced healthcare costs. Moreover, advancements in technology and the integration of automation have revolutionized the IVD market. Automated systems, such as point-of-care testing devices and molecular diagnostics, have streamlined the diagnostic process, enabling faster and more accurate results. Additionally, the growing focus on personalized medicine and precision diagnostics has boosted the demand for specialized in vitro diagnostic tests. These tests help tailor treatment plans to individual patients' specific genetic and molecular characteristics, optimizing therapeutic outcomes and minimizing adverse reactions.

In Vitro Diagnostics Market Trends/Drivers:

Various technological advancements and automation

The rapid pace of technological innovation has revolutionized the In vitro diagnostics (IVD) market. Advanced technologies, such as molecular diagnostics, next-generation sequencing, and microfluidics, have enabled more accurate and sensitive testing methods. Automation has streamlined diagnostic processes, reducing human errors and increasing efficiency. Automated systems like point-of-care testing devices have facilitated faster results, enabling timely decision-making in patient care. These advancements not only enhance diagnostic accuracy but also contribute to cost savings and improved patient outcomes. Moreover, automation has extended the reach of diagnostic testing to remote or resource-limited areas, addressing healthcare disparities and improving patient access to essential diagnostic services. The integration of artificial intelligence and machine learning algorithms has further enhanced the analytical capabilities of diagnostic systems, allowing for more precise and personalized test interpretations. As technology continues to advance, the In vitro diagnostics market is expected to witness continued growth, with an ever-expanding range of diagnostic tests and applications.

The increasing prevalence of chronic diseases

The rising prevalence of chronic diseases, such as diabetes, cardiovascular disorders, and cancer, has been a key driver in the growth of the IVD market. With aging populations and lifestyle changes, chronic conditions have become more prevalent globally. In vitro diagnostics play a crucial role in the early detection, monitoring, and management of these diseases. Diagnostic tests assist healthcare professionals in making informed treatment decisions, leading to better disease management and improved quality of life for patients. Moreover, the prevalence of chronic diseases has prompted a paradigm shift towards preventive healthcare. Early detection and intervention are essential in preventing the progression of chronic conditions and reducing the burden on healthcare systems. In vitro diagnostics facilitate early screening and identification of risk factors, enabling timely preventive measures. This emphasis on preventive healthcare has spurred the adoption of IVD tests in routine health check-ups and wellness programs.

The growing emphasis on personalized medicine

The growing focus on personalized medicine has significantly impacted the IVD market. Personalized medicine aims to tailor medical treatment to individual patients based on their genetic makeup, lifestyle, and other factors. In vitro diagnostics, such as genetic testing and companion diagnostics, provide critical insights into patients' unique characteristics, enabling targeted therapies and avoiding unnecessary treatments or adverse reactions. Precision diagnostics, enabled by advanced technologies like Next-Generation Sequencing (NGS) and companion diagnostics, facilitate the identification of specific disease subtypes and molecular targets. As precision medicine gains prominence, the demand for specialized diagnostic tests continues to rise. Healthcare providers and pharmaceutical companies are increasingly investing in research and development to identify new biomarkers and create innovative diagnostic solutions to support precision medicine initiatives.

In Vitro Diagnostics Industry Segmentation:

Breakup by Test Type:

  • Clinical Chemistry
  • Molecular Diagnostics
  • Immunodiagnostics
  • Hematology
  • Others

Molecular diagnostics represents the most popular test type

Molecular diagnostics offer high levels of accuracy and sensitivity in disease detection. They can identify even low concentrations of target molecules, enabling early diagnosis and precise monitoring of diseases. This level of sensitivity is particularly crucial in the detection of infectious diseases, genetic disorders, and certain types of cancer, where early intervention is vital for successful treatment. Moreover, molecular diagnostics play a key role in the advancement of personalized medicine. By analyzing an individual's genetic makeup or specific biomarkers, these tests can tailor treatment plans to each patient's unique characteristics. This approach optimizes therapeutic outcomes, minimizes adverse effects, and enhances overall patient care, contributing to the growing demand for personalized healthcare solutions.

Breakup by Product:

  • Reagents and Kits
  • Instruments

Reagents and kits represent the leading segment

Reagents and kits are fundamental components of diagnostic tests. They contain the necessary substances and chemicals required to perform specific assays and analyze patient samples. Diagnostic laboratories and healthcare facilities rely heavily on reagents and kits to conduct a wide range of tests, from routine screenings to complex molecular diagnostics. Moreover, Reagents and kits are designed to be user-friendly and standardized, ensuring consistent and reliable results across different laboratories and testing sites. They simplify the testing process, reducing the need for extensive manual preparation and minimizing the risk of errors. Standardization also facilitates inter-laboratory comparability, making it easier for healthcare providers to interpret and act upon test results.

Breakup by Usability:

  • Disposable IVD Devices
  • Reusable IVD Devices

Disposable IVD devices are designed for single-use and are discarded after a single patient interaction or testing procedure. They are pre-sterilized and come in a ready-to-use format, which eliminates the need for cleaning, disinfection, or reprocessing after each use. Healthcare providers find disposable IVD devices convenient and time-saving, as they eliminate the need for complex and time-consuming reprocessing procedures. This is especially advantageous in high-volume testing environments.

Reusable IVD devices, as the name suggests, can be used multiple times after appropriate cleaning, sterilization, and maintenance. They are made of durable materials that can withstand repeated use without compromising their performance. They also offer greater flexibility in terms of test customization and parameter adjustments, making them suitable for research and specialized testing needs.

Breakup by Application:

  • Infectious Disease
  • Diabetes
  • Cancer/Oncology
  • Cardiology
  • Autoimmune Disease
  • Nephrology
  • Others

Infectious diseases currently dominate the market

Infectious diseases pose significant global health challenges, and outbreaks or pandemics can have severe consequences on public health and economies. The COVID-19 pandemic, for example, has highlighted the critical role of diagnostic testing in controlling the spread of infectious diseases. Besides, infectious diseases have a high incidence and prevalence rate, affecting millions of people worldwide. Common infectious diseases such as influenza, tuberculosis, hepatitis, and sexually transmitted infections continue to impact communities across the globe. Moreover, in vitro diagnostics offer a rapid and reliable way to identify infectious agents, allowing healthcare providers to initiate appropriate therapies, implement infection control measures, and prevent further transmission.

Breakup by End User:

  • Hospitals Laboratories
  • Clinical Laboratories
  • Point-of-care Testing Centers
  • Academic Institutes
  • Patients
  • Others

Hospital laboratories are an essential part of healthcare facilities, providing diagnostic testing services to inpatients and outpatients. These laboratories are equipped with a wide range of IVD instruments and reagents to perform various tests, including clinical chemistry, hematology, microbiology, and immunology. Hospitals rely on timely and accurate diagnostic results from their in-house laboratories to aid in patient diagnosis, treatment, and disease management.

Clinical laboratories, also known as independent or reference laboratories, are separate entities that offer diagnostic testing services to healthcare providers, hospitals, clinics, and other healthcare settings. They often handle high-volume and specialized tests that may not be available in all hospital laboratories. Clinical laboratories serve as centralized testing facilities, supporting multiple healthcare facilities with their comprehensive testing capabilities.

Point-of-care testing (POCT) centers represent a rapidly growing segment in the IVD market. These centers provide diagnostic tests at or near the location where patient care is delivered. POCT devices offer rapid results, allowing for immediate treatment decisions and interventions. Point-of-care testing centers are especially valuable in emergency rooms, ambulances, nursing homes, and remote or resource-limited settings where quick diagnosis is critical.

Academic institutes, including research universities and medical schools, contribute to the IVD market through research, development, and education. They play a pivotal role in advancing diagnostic technologies, discovering new biomarkers, and evaluating the effectiveness of diagnostic tests. Academic institutes often collaborate with diagnostic companies to conduct clinical trials and validate the performance of novel diagnostic assays.

Patients are becoming increasingly involved in their healthcare decisions, including diagnostic testing. The IVD market caters to the direct-to-consumer testing trend, where patients can access certain diagnostic tests without a healthcare provider's prescription. These tests allow individuals to monitor their health status, identify risk factors, and take proactive steps towards better health management.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America accounts for the majority of market share

The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (United States, Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others); Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others); Latin America (Brazil, Mexico, Others); and the Middle East and Africa. According to the report, North America was the largest market for in vitro diagnostics.

North America boasts a well-developed and advanced healthcare infrastructure, including modern hospitals, clinical laboratories, and research institutions. The region's robust healthcare system supports a high volume of diagnostic testing, driving the demand for IVD products and services. Besides, North America is at the forefront of technological innovations in the IVD industry. The region is home to many leading diagnostic companies and research institutions that invest heavily in research and development, leading to the creation of cutting-edge diagnostic technologies and products. Moreover, the region has stringent regulatory standards for diagnostic products, ensuring safety and efficacy. Companies operating in the region must comply with rigorous quality control measures, which helps build trust in the reliability of IVD products.

Competitive Landscape:

The competitive landscape of the In vitro diagnostics (IVD) market is characterized by a diverse and highly competitive environment, with numerous companies vying for market share. They are developing advanced technologies, novel biomarkers, and point-of-care testing devices to meet the evolving needs of the healthcare industry. They are engaging in mergers and acquisitions (M&As) to expand their product portfolios, gain access to new markets, and enhance their technological capabilities. They are also expanding their market presence by establishing distribution networks in new regions or countries. Moreover, companies are embracing digitalization and investing in digital diagnostic solutions. This includes the development of digital pathology, remote monitoring, and telehealth solutions to enhance diagnostic efficiency and accessibility.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Biomerieux SA
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd
  • Fujifilm Holdings Corporation
  • Illumina Inc.
  • Qiagen N.V
  • Quest Diagnostics
  • Shimadzu Corporation
  • Siemens Healthcare GmbH
  • Sysmex Corporation

Key Questions Answered in This Report

  • 1.What is the IVD market?
  • 2.What is the global outlook on the in vitro diagnostics industry?
  • 3.What is the market size of in vitro diagnostics?
  • 4.What are the key factors driving the in vitro diagnostics market?
  • 5.Which region accounts for the largest in vitro diagnostics market share?
  • 6.Which are the leading companies in the global in vitro diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global In Vitro Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test Type

  • 6.1 Clinical Chemistry
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Molecular Diagnostics
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Immunodiagnostics
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Hematology
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Reagents and Kits
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Instruments
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Usability

  • 8.1 Disposable IVD Devices
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Reusable IVD Devices
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Infectious Disease
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Diabetes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Cancer/Oncology
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Cardiology
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Autoimmune Disease
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast
  • 9.6 Nephrology
    • 9.6.1 Market Trends
    • 9.6.2 Market Forecast
  • 9.7 Others
    • 9.7.1 Market Trends
    • 9.7.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Hospitals Laboratories
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Clinical Laboratories
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Point-of-care Testing Centers
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Academic Institutes
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Patients
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast
  • 10.6 Others
    • 10.6.1 Market Trends
    • 10.6.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Abbott Laboratories
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Agilent Technologies Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 Biomerieux SA
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 Bio-Rad Laboratories Inc.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 F. Hoffmann-La Roche Ltd
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 SWOT Analysis
    • 16.3.6 Fujifilm Holdings Corporation
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
      • 16.3.6.4 SWOT Analysis
    • 16.3.7 Illumina Inc.
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 Qiagen NV
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Quest Diagnostics
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Shimadzu Corporation
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
      • 16.3.10.4 SWOT Analysis
    • 16.3.11 Siemens Healthcare GmbH
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
    • 16.3.12 Sysmex Corporation
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: In Vitro Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: In Vitro Diagnostics Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: In Vitro Diagnostics Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: In Vitro Diagnostics Market: Breakup by Test Type (in %), 2024
  • Figure 5: Global: In Vitro Diagnostics Market: Breakup by Product (in %), 2024
  • Figure 6: Global: In Vitro Diagnostics Market: Breakup by Usability (in %), 2024
  • Figure 7: Global: In Vitro Diagnostics Market: Breakup by Application (in %), 2024
  • Figure 8: Global: In Vitro Diagnostics Market: Breakup by End User (in %), 2024
  • Figure 9: Global: In Vitro Diagnostics Market: Breakup by Region (in %), 2024
  • Figure 10: Global: In Vitro Diagnostics (Clinical Chemistry) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: In Vitro Diagnostics (Clinical Chemistry) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: In Vitro Diagnostics (Molecular Diagnostics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: In Vitro Diagnostics (Molecular Diagnostics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: In Vitro Diagnostics (Immunodiagnostics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: In Vitro Diagnostics (Immunodiagnostics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: In Vitro Diagnostics (Hematology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: In Vitro Diagnostics (Hematology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: In Vitro Diagnostics (Other Test Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: In Vitro Diagnostics (Other Test Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: In Vitro Diagnostics (Reagents and Kits) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: In Vitro Diagnostics (Reagents and Kits) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: In Vitro Diagnostics (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: In Vitro Diagnostics (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: In Vitro Diagnostics (Disposable IVD Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: In Vitro Diagnostics (Disposable IVD Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: In Vitro Diagnostics (Reusable IVD Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: In Vitro Diagnostics (Reusable IVD Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: In Vitro Diagnostics (Infectious Disease) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: In Vitro Diagnostics (Infectious Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: In Vitro Diagnostics (Diabetes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: In Vitro Diagnostics (Diabetes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: In Vitro Diagnostics (Cancer/Oncology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: In Vitro Diagnostics (Cancer/Oncology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: In Vitro Diagnostics (Cardiology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: In Vitro Diagnostics (Cardiology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: In Vitro Diagnostics (Autoimmune Disease) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: In Vitro Diagnostics (Autoimmune Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Global: In Vitro Diagnostics (Nephrology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Global: In Vitro Diagnostics (Nephrology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Global: In Vitro Diagnostics (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Global: In Vitro Diagnostics (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Global: In Vitro Diagnostics (Hospitals Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Global: In Vitro Diagnostics (Hospitals Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Global: In Vitro Diagnostics (Clinical Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Global: In Vitro Diagnostics (Clinical Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Global: In Vitro Diagnostics (Point-of-care Testing Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Global: In Vitro Diagnostics (Point-of-care Testing Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Global: In Vitro Diagnostics (Academic Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Global: In Vitro Diagnostics (Academic Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Global: In Vitro Diagnostics (Patients) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Global: In Vitro Diagnostics (Patients) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Global: In Vitro Diagnostics (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Global: In Vitro Diagnostics (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: North America: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: North America: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: United States: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: United States: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Canada: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Canada: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Asia-Pacific: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Asia-Pacific: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: China: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: China: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Japan: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Japan: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: India: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: India: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: South Korea: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: South Korea: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Australia: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Australia: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Indonesia: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Indonesia: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Europe: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Europe: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Germany: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Germany: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: France: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: France: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: United Kingdom: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: United Kingdom: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Italy: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Italy: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Spain: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 87: Spain: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 88: Russia: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 89: Russia: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 90: Others: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 91: Others: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 92: Latin America: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 93: Latin America: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 94: Brazil: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 95: Brazil: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 96: Mexico: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 97: Mexico: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 98: Others: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 99: Others: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 100: Middle East and Africa: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 101: Middle East and Africa: In Vitro Diagnostics Market: Breakup by Country (in %), 2024
  • Figure 102: Middle East and Africa: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 103: Global: In Vitro Diagnostics Industry: SWOT Analysis
  • Figure 104: Global: In Vitro Diagnostics Industry: Value Chain Analysis
  • Figure 105: Global: In Vitro Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: In Vitro Diagnostics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: In Vitro Diagnostics Market Forecast: Breakup by Test Type (in Million USD), 2025-2033
  • Table 3: Global: In Vitro Diagnostics Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 4: Global: In Vitro Diagnostics Market Forecast: Breakup by Usability (in Million USD), 2025-2033
  • Table 5: Global: In Vitro Diagnostics Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 6: Global: In Vitro Diagnostics Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 7: Global: In Vitro Diagnostics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 8: Global: In Vitro Diagnostics Market: Competitive Structure
  • Table 9: Global: In Vitro Diagnostics Market: Key Players